text_1: Monoclonal antibody targeting of N-cadherin inhibits metastasis.
text_2: Comparing gene expression in isogenic androgen-dependent and CRPC xenografts, we found a reproducible increase in N-cadherin expression, which was also elevated in primary and metastatic tumors of individuals with CRPC.